| Q42241742 | Adrenoceptor blocking, hemodynamic and coronary effects of YM-09538, a new combined α- and β-adrenoceptor blocking drug, in anesthetized dogs |
| Q54548901 | Alpha-adrenergic vasoconstriction in arterial and arteriolar sections of the canine coronary circulation |
| Q43893156 | Alpha-adrenoceptor subtypes and regional myocardial blood flow distribution during coronary occlusion in dogs |
| Q39286967 | Coronary wedge pressure: a predictor of restenosis after coronary balloon angioplasty |
| Q69543588 | Effect of nifedipine on dipyridamole thallium-201 myocardial scintigraphy |
| Q39626559 | Effect of propranolol and nitroglycerin plus methoxamine on transmural creatine kinase activity after acute coronary occlusion |
| Q42228735 | Fentanyl, Na-pentobarbital and halothane influence myocardial infarct size |
| Q53572049 | Hexose transport in normal and SV40-transformed human endothelial cells in culture |
| Q32054978 | Myocardial perfusion imaging findings and the role of adenosine in the warm-up angina phenomenon |
| Q38378869 | Pharmacology of acute effort angina |
| Q34297736 | Protection against ischemia: a physiological function of the renin-angiotensin system |
| Q83659593 | Reprint of: the paradox of α-adrenergic coronary vasoconstriction revisited |
| Q71606952 | Role of adenosine in pathogenesis of syndrome X: assessment with coronary hemodynamic measurements and thallium-201 myocardial single-photon emission computed tomography |
| Q54531888 | Segmental response to sympathetic activation in the canine coronary circulation |
| Q37860513 | The paradox of α-adrenergic coronary vasoconstriction revisited |